Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
Tatiana L Karonova, Igor V Kudryavtsev, Ksenia A Golovatyuk, Arthur D Aquino, Olga V Kalinina, Alena T Chernikova, Ekaterina K Zaikova, Denis A Lebedev, Ekaterina S Bykova, Alexey S Golovkin, Evgeny V Shlyakhto
Pharmaceuticals, doi:10.3390/ph15030305
A low 25-hydroxyvitamin D (25(OH)D) level is considered as an independent risk factor for COVID-19 severity. However, the association between vitamin D status and outcomes in COVID-19 is controversial. In the present study we investigate the association between the serum 25(OH)D level, immune response, and clinical disease course in patients with COVID-19. A total of 311 patients hospitalized with COVID-19 were enrolled. For patients with a vitamin D deficiency/insufficiency, the prevalence of severe COVID-19 was higher than in those with a normal 25(OH)D level (p < 0.001). The threshold of 25(OH)D level associated with mortality was 11.4 ng/mL (p = 0.003, ROC analysis). The frequency of CD3+CD4+ T helper (Th) cells was decreased in patients with 25(OH)D level ≤ 11.4 ng/mL, compared to healthy controls (HCs). There were no differences in the frequency of naive, central memory (CM), effector memory (EM), and terminally differentiated effector memory Th cells in patients with COVID-19 compared to HCs. The frequency of T-follicular helpers was decreased both in patients with 25(OH)D level > 11.4 ng/mL (p < 0.001) and 25(OH)D level ≤ 11.4 ng/mL (p = 0.003) compared to HCs. Patients with 25(OH)D level > 11.4 ng/mL had an increased frequency of Th2 CM (p = 0.010) and decreased Th17 CM (p < 0.001). While the frequency of Th2 EM was significantly increased, the frequency of Th17 EM was significantly decreased in both groups compared to HCs. Thus, 25(OH)D level is an independent risk factor for the disease severity and mortality in patients with COVID-19. We demonstrate that the serum 25(OH)D level ≤ 11.4 ng/mL is associated with the stimulation of Th2 and the downregulation of Th17 cell polarization of the adaptive immunity in patients with COVID-19.
Conflicts of Interest: The authors declare no conflict of interest.
References
Alsafar, Grant, Hijazi, Uddin, Alkaabi et al., COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents, Nutrients,
doi:10.3390/nu13051714Baeke, Korf, Overbergh, Van Etten, Verstuyf et al., Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2010.03.037Barbarash, Kudryavtsev, Rutkovskaya, Golovkin, Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves, Mediat. Inflamm,
doi:10.1155/2016/1937564Boonstra, Barrat, Crain, Heath, Savelkoul et al., 1alpha,25-Dihydroxyvitamin d3 has a direct effect on I CD4(+) T cells to enhance the development of Th2 cells, J. Immunol,
doi:10.4049/jimmunol.167.9.4974Braun, Loyal, Frentsch, Wendisch, Georg et al., SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19, Nature,
doi:10.1038/s41586-020-2598-9Carpagnano, Di Lecce, Quaranta, Zito, Buonamico et al., Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J. Endocrinol. Investig,
doi:10.1007/s40618-020-01370-xCascella, Rajnik, Aleem, Dulebohn, Di Napoli et al., Evaluation, and Treatment of Coronavirus (COVID-19)
Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front. Public Health
Chun, Liu, Modlin, Adams, Hewison, Impact of vitamin D on immune function: Lessons learned from genome-wide analysis, Front. Physiol,
doi:10.3389/fphys.2014.00151Currie, Findlay, Mchugh, Mackellar, Man et al., The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus, PLoS ONE,
doi:10.1371/journal.pone.0073659Dankers, Davelaar, Van Hamburg, Van De Peppel, Colin et al., Human Memory Th17 Cell Populations Change into Anti-inflammatory Cells with Regulatory Capacity Upon Exposure to Active Vitamin D, Front. Immunol,
doi:10.3389/fimmu.2019.01504Dissanayake, De Silva, Sumanatilleke, De Silva, Gamage et al., Prognostic and therapeutic role of vitamin D in COVID-19: Systematic review and meta-analysis, J. Clin. Endocrinol. Metab,
doi:10.1210/clinem/dgab892Dupuis, Pagano, Pierdominici, Ortona, The role of vitamin D in autoimmune diseases: Could sex make the difference?, Biol. Sex Differ,
doi:10.1186/s13293-021-00358-3Gallelli, Mannino, Luciani, De Sire, Mancuso et al., Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study, Nutrients,
doi:10.3390/nu13113932Golovkin, Kalinina, Bezrukikh, Aquino, Zaikova et al., Imbalanced Immune Response of T cell and B cell Subsets in Patients with Moderate and Severe COVID-19, Viruses,
doi:10.3390/v13101966Grant, Al Anouti, Boucher, Dursun, Gezen-Ak et al., A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health, Nutrients,
doi:10.3390/nu14030639Heaney, Functional indices of vitamin D status and ramifications of vitamin D deficiency, Am. J. Clin. Nutr,
doi:10.1093/ajcn/80.6.1706SHewison, Freeman, Hughes, Evans, Bland et al., Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells, J. Immunol,
doi:10.4049/jimmunol.170.11.5382Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline, J. Clin. Endocrinol. Metab,
doi:10.1210/jc.2011-0385Joshi, Pantalena, Liu, Gaffen, Liu et al., 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A, Mol. Cell. Biol,
doi:10.1128/MCB.05020-11Karonova, Andreeva, Golovatuk, Bykova, Simanenkova et al., Low 25(OH)D Level is Associated with Severe Course and Poor Prognosis in COVID-19, Nutrients,
doi:10.3390/nu13093021Khalifa, Swilam, El-Wahed, Du, El-Seedi et al., Beyond the Pandemic: COVID-19 Pandemic Changed the Face of Life, Int. J. Environ. Res. Public Health,
doi:10.3390/ijerph18115645Kota, Sabbah, Chang, Harnack, Xiang et al., Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus, J. Biol. Chem,
doi:10.1074/jbc.M710415200Kudryavtsev, Kalinina, Bezrukikh, Melnik, Golovkin, The significance of phenotyping and quantification of plasma extracellular vesicles levels using high-sensitivity flow cytometry during COVID-19 treatment, Viruses,
doi:10.3390/v13050767Kudryavtsev, Serebriakova, Zhiduleva, Murtazalieva, Titov et al., CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease, Front. Genet,
doi:10.3389/fgene.2019.00604Macaya, Espejo Paeres, Valls, Fernandez-Ortiz, Gonzalez Del Castillo et al., Interaction between age and vitamin D deficiency in severe COVID-19 infection, Nutr. Hosp
Malkova, Kudlay, Kudryavtsev, Starshinova, Yablonskiy et al., Immunogenetic Predictors of Severe COVID-19, Vaccines,
doi:10.3390/vaccines9030211Meinken, Kamen, Wagner, Bals, Steinmeyer et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science,
doi:10.1126/science.1123933Mercola, Grant, Wagner, Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity, Nutrients,
doi:10.3390/nu12113361Morita, Schmitt, Bentebibel, Ranganathan, Bourdery et al., Human blood CXCR5(+) CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion, Immunity,
doi:10.1016/j.immuni.2010.12.012Panagiotou, Tee, Ihsan, Athar, Marchitelli et al., Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity, Clin. Endocrinol,
doi:10.1111/cen.14276Pizzini, Aichner, Sahanic, Bohm, Egger et al., Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry, Nutrients
Prevention, Diagnosis and Treatment of New Coronavirus Infection (COVID-19)
Rydyznski Moderbacher, Ramirez, Dan, Grifoni, Hastie et al., Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity, Cell,
doi:10.1016/j.cell.2020.09.038Sallusto, Lenig, Förster, Lipp, Lanzavecchia, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature,
doi:10.1038/44385Selvaraj, Harishankar, Afsal, Vitamin, Immuno-modulation and tuberculosis treatment, Can. J. Physiol. Pharmacol,
doi:10.1139/cjpp-2014-0386Sigmundsdottir, Pan, Debes, Alt, Habtezion et al., DCs metabolize sunlight-induced vitamin D to 'program' T cell attraction to the epidermal chemokine CCL27, Nat. Immunol,
doi:10.1038/ni1433Tan, Linster, Tan, Le Bert, Chia et al., Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients, Cell Rep,
doi:10.1016/j.celrep.2021.108728Tang, Zhou, Luger, Zhu, Silver et al., Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response, J. Immunol,
doi:10.4049/jimmunol.0801543Todosenko, Vulf, Yurova, Khaziakhmatova, Mikhailova et al., Causal Links between Hypovitaminosis D and Dysregulation of the T Cell Connection of Immunity Associated with Obesity and Concomitant Pathologies, Biomedicines,
doi:10.3390/biomedicines9121750Urashima, Segawa, Okazaki, Kurihara, Wada et al., Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, Am. J. Clin. Nutr,
doi:10.3945/ajcn.2009.29094Urry, Chambers, Xystrakis, Dimeloe, Richards et al., The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells, Eur. J. Immunol,
doi:10.1002/eji.201242370Wang, Nestel, Bourdeau, Nagai, Wang et al., Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression, J. Immunol,
doi:10.4049/jimmunol.173.5.2909Wu, Sun, Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection, Discov. Med
{ 'indexed': {'date-parts': [[2024, 4, 2]], 'date-time': '2024-04-02T15:11:53Z', 'timestamp': 1712070713868},
'reference-count': 49,
'publisher': 'MDPI AG',
'issue': '3',
'license': [ { 'start': { 'date-parts': [[2022, 3, 2]],
'date-time': '2022-03-02T00:00:00Z',
'timestamp': 1646179200000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>A low 25-hydroxyvitamin D (25(OH)D) level is considered as an independent risk factor '
'for COVID-19 severity. However, the association between vitamin D status and outcomes in '
'COVID-19 is controversial. In the present study we investigate the association between the '
'serum 25(OH)D level, immune response, and clinical disease course in patients with COVID-19. '
'A total of 311 patients hospitalized with COVID-19 were enrolled. For patients with a vitamin '
'D deficiency/insufficiency, the prevalence of severe COVID-19 was higher than in those with a '
'normal 25(OH)D level (p < 0.001). The threshold of 25(OH)D level associated with mortality '
'was 11.4 ng/mL (p = 0.003, ROC analysis). The frequency of CD3+CD4+ T helper (Th) cells was '
'decreased in patients with 25(OH)D level ≤ 11.4 ng/mL, compared to healthy controls (HCs). '
'There were no differences in the frequency of naive, central memory (CM), effector memory '
'(EM), and terminally differentiated effector memory Th cells in patients with COVID-19 '
'compared to HCs. The frequency of T-follicular helpers was decreased both in patients with '
'25(OH)D level > 11.4 ng/mL (p < 0.001) and 25(OH)D level ≤ 11.4 ng/mL (p = 0.003) '
'compared to HCs. Patients with 25(OH)D level > 11.4 ng/mL had an increased frequency of '
'Th2 CM (p = 0.010) and decreased Th17 CM (p < 0.001). While the frequency of Th2 EM was '
'significantly increased, the frequency of Th17 EM was significantly decreased in both groups '
'compared to HCs. Thus, 25(OH)D level is an independent risk factor for the disease severity '
'and mortality in patients with COVID-19. We demonstrate that the serum 25(OH)D level ≤ 11.4 '
'ng/mL is associated with the stimulation of Th2 and the downregulation of Th17 cell '
'polarization of the adaptive immunity in patients with COVID-19.</jats:p>',
'DOI': '10.3390/ph15030305',
'type': 'journal-article',
'created': {'date-parts': [[2022, 3, 3]], 'date-time': '2022-03-03T03:53:25Z', 'timestamp': 1646279605000},
'page': '305',
'source': 'Crossref',
'is-referenced-by-count': 12,
'title': 'Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19',
'prefix': '10.3390',
'volume': '15',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-1547-0123',
'authenticated-orcid': False,
'given': 'Tatiana L.',
'family': 'Karonova',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0001-7204-7850',
'authenticated-orcid': False,
'given': 'Igor V.',
'family': 'Kudryavtsev',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-0651-7110',
'authenticated-orcid': False,
'given': 'Ksenia A.',
'family': 'Golovatyuk',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0001-6516-7184',
'authenticated-orcid': False,
'given': 'Arthur D.',
'family': 'Aquino',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-1916-5705',
'authenticated-orcid': False,
'given': 'Olga V.',
'family': 'Kalinina',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-4878-6909',
'authenticated-orcid': False,
'given': 'Alena T.',
'family': 'Chernikova',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-0584-2330',
'authenticated-orcid': False,
'given': 'Ekaterina K.',
'family': 'Zaikova',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-1808-1331',
'authenticated-orcid': False,
'given': 'Denis A.',
'family': 'Lebedev',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-9342-507X',
'authenticated-orcid': False,
'given': 'Ekaterina S.',
'family': 'Bykova',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-7577-628X',
'authenticated-orcid': False,
'given': 'Alexey S.',
'family': 'Golovkin',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-2929-0980',
'authenticated-orcid': False,
'given': 'Evgeny V.',
'family': 'Shlyakhto',
'sequence': 'additional',
'affiliation': []}],
'member': '1968',
'published-online': {'date-parts': [[2022, 3, 2]]},
'reference': [ {'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijerph18115645'},
{ 'key': 'ref2',
'series-title': 'StatPearls [Internet]',
'article-title': 'Features, Evaluation, and Treatment of Coronavirus (COVID-19)',
'author': 'Cascella',
'year': '2022'},
{'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1139/cjpp-2014-0386'},
{'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.1126/science.1123933'},
{'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.4049/jimmunol.173.5.2909'},
{'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.3945/ajcn.2009.29094'},
{'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu12113361'},
{'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/cen.14276'},
{'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s40618-020-01370-x'},
{'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu12092775'},
{'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.20960/nh.03193'},
{'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu13093021'},
{'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/clinem/dgab892'},
{'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMra070553'},
{'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/ajcn/80.6.1706S'},
{'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jsbmb.2010.03.037'},
{'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.4049/jimmunol.170.11.5382'},
{'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0073659'},
{'key': 'ref19', 'doi-asserted-by': 'publisher', 'DOI': '10.1074/jbc.M710415200'},
{'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0138152'},
{'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/rmdopen-2020-001454'},
{'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.4049/jimmunol.167.9.4974'},
{'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.2310/JIM.0b013e31821b8755'},
{'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu14030639'},
{'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.immuni.2010.12.012'},
{'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fpubh.2021.736665'},
{'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu13051714'},
{'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/v13101966'},
{'key': 'ref29', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/v13050767'},
{'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/vaccines9030211'},
{'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu13113932'},
{'key': 'ref32', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s13293-021-00358-3'},
{'key': 'ref33', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.coph.2010.04.001'},
{'key': 'ref34', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fphys.2014.00151'},
{'key': 'ref35', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/MCB.05020-11'},
{'key': 'ref36', 'doi-asserted-by': 'publisher', 'DOI': '10.4049/jimmunol.0801543'},
{'key': 'ref37', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/biomedicines9121750'},
{'key': 'ref38', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/eji.201242370'},
{'key': 'ref39', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/ni1433'},
{'key': 'ref40', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fimmu.2019.01504'},
{'key': 'ref41', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cell.2021.01.007'},
{'key': 'ref42', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cell.2020.09.038'},
{'key': 'ref43', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.celrep.2021.108728'},
{'key': 'ref44', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2598-9'},
{ 'key': 'ref45',
'unstructured': 'Prevention, Diagnosis and Treatment of New Coronavirus Infection '
'(COVID-19)http://www.consultant.ru/law/hotdocs/65400.html/'},
{'key': 'ref46', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/jc.2011-0385'},
{'key': 'ref47', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/44385'},
{'key': 'ref48', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2016/1937564'},
{'key': 'ref49', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fgene.2019.00604'}],
'container-title': 'Pharmaceuticals',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/1424-8247/15/3/305/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 3, 3]],
'date-time': '2022-03-03T04:33:35Z',
'timestamp': 1646282015000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/1424-8247/15/3/305'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 3, 2]]},
'references-count': 49,
'journal-issue': {'issue': '3', 'published-online': {'date-parts': [[2022, 3]]}},
'alternative-id': ['ph15030305'],
'URL': 'http://dx.doi.org/10.3390/ph15030305',
'relation': {},
'ISSN': ['1424-8247'],
'subject': ['Drug Discovery', 'Pharmaceutical Science', 'Molecular Medicine'],
'container-title-short': 'Pharmaceuticals',
'published': {'date-parts': [[2022, 3, 2]]}}
